192 related articles for article (PubMed ID: 2328496)
1. Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines.
Chatterjee S; Trivedi D; Petzold SJ; Berger NA
Cancer Res; 1990 May; 50(9):2713-8. PubMed ID: 2328496
[TBL] [Abstract][Full Text] [Related]
2. Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide.
Chatterjee S; Cheng MF; Berger SJ; Berger NA
Cancer Res; 1994 Aug; 54(16):4405-11. PubMed ID: 8044789
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.
Hashimoto H; Chatterjee S; Berger NA
Cancer Res; 1995 Sep; 55(18):4029-35. PubMed ID: 7664276
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) and the response of cells to ionizing radiation.
Oleinick NL; Evans HH
Radiat Res; 1985 Jan; 101(1):29-46. PubMed ID: 3918331
[TBL] [Abstract][Full Text] [Related]
5. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO
Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
[TBL] [Abstract][Full Text] [Related]
6. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity.
Hirota H; Gosky D; Berger NA; Chatterjee S
Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines.
Chatterjee S; Cheng MF; Trivedi D; Petzold SJ; Berger NA
Cancer Commun; 1989; 1(6):389-94. PubMed ID: 2562007
[TBL] [Abstract][Full Text] [Related]
8. Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability.
Chatterjee S; Hirschler NV; Petzold SJ; Berger SJ; Berger NA
Exp Cell Res; 1989 Sep; 184(1):1-15. PubMed ID: 2507334
[TBL] [Abstract][Full Text] [Related]
9. Baseline sister chromatid exchange in human cell lines with different levels of poly(ADP-ribose) polymerase.
Jorgensen TJ; Leonard JC; Thraves PJ; Dritschilo A
Radiat Res; 1991 Jul; 127(1):107-10. PubMed ID: 1906188
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines.
Spiridonidis CA; Chatterjee S; Petzold SJ; Berger NA
Cancer Res; 1989 Feb; 49(3):644-50. PubMed ID: 2535964
[TBL] [Abstract][Full Text] [Related]
11. Cellular NAD+ and ATP levels in alkylation-induced cytotoxicity enhanced by an inhibitor of poly(ADP-ribose) synthesis.
Wells RL; Shibuya ML; Ben-Hur E; Elkind MM
Cancer Biochem Biophys; 1990 Apr; 11(2):97-105. PubMed ID: 2116938
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosylation, DNA repair, cell differentiation and cancer.
Shall S
Princess Takamatsu Symp; 1983; 13():3-25. PubMed ID: 6317641
[TBL] [Abstract][Full Text] [Related]
13. Influence of inhibitors of poly(ADP-ribose) polymerase on DNA repair, chromosomal alterations, and mutations.
Natarajan AT; van Zeeland AA; Zwanenburg TS
Princess Takamatsu Symp; 1983; 13():227-42. PubMed ID: 6317638
[TBL] [Abstract][Full Text] [Related]
14. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
15. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of X-ray- and ultraviolet light-induced transformation in vitro by modifiers of poly(ADP-ribose) synthesis.
Borek C; Ong A; Morgan WF; Cleaver JE
Radiat Res; 1984 Aug; 99(2):219-27. PubMed ID: 6463203
[TBL] [Abstract][Full Text] [Related]
17. DNA repair, ADP-ribosylation and pyridine nucleotide metabolism as targets for cancer chemotherapy.
Berger NA; Berger SJ; Gerson SL
Anticancer Drug Des; 1987 Oct; 2(2):203-9. PubMed ID: 3329525
[TBL] [Abstract][Full Text] [Related]
18. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences.
Whitacre CM; Hashimoto H; Tsai ML; Chatterjee S; Berger SJ; Berger NA
Cancer Res; 1995 Sep; 55(17):3697-701. PubMed ID: 7641178
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose): spectator or participant in excision repair of DNA damage.
Cleaver JE; Bodell WJ; Borek C; Morgan WF; Schwartz JL
Princess Takamatsu Symp; 1983; 13():195-207. PubMed ID: 6686227
[TBL] [Abstract][Full Text] [Related]
20. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Aida T; Bodell WJ
Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
